Continuation Patent

What It Means

A continuation is a type of patent application that shares the same specification and disclosure as a previously filed "parent" application but presents new or different claims. Continuations allow inventors to seek broader or narrower protection on the same invention without starting over. Because the continuation claims priority from the parent's filing date, it gets the benefit of the earlier date for prior art purposes, even though it may be filed years later. There are two main types: regular continuations (same disclosure, different claims) and continuation-in-part (CIP) applications, which add new matter to the original disclosure. Continuations are a powerful strategic tool and a common feature of large patent portfolios. A company might file an initial application with broad claims, then file continuations targeting specific competitor products that emerge later — all while claiming the original priority date. This practice is controversial because it can extend the effective life of a patent family well beyond the original 20-year term. While each individual patent expires 20 years from its own filing date, continuation applications filed years after the parent can create overlapping patent terms that stretch protection for decades. In pharmaceutical patent strategies, continuation patents are a key component of evergreening — the practice of extending market exclusivity beyond the original patent by filing new patents on formulations, dosages, or delivery methods. Patent portfolio analysts track continuation families to understand the true scope and duration of a company's intellectual property protection.

Frequently Asked Questions